![Page 1: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/1.jpg)
The Cell Cycle and its implications in diseases
Hansjörg HauserDept. of Gene Regulation and DifferentiationMolecular BiotechnologyHZI, Braunschweig
![Page 2: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/2.jpg)
Cell division is a prerequisite for life
•Microorganisms reproduce by cell division
•Mammals need cell division during embryogenesis and for tissue homeostasis
Example: Adult humans produce several milions of new cells per second (more than 1011 per day – about 100 grams)
![Page 3: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/3.jpg)
Cell division can be fast or slow
•Microorganisms > 20 min per division
•Multicellular organisms: 8 min and several weeks per division
•All species can halt cell division
![Page 4: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/4.jpg)
Neben einem zum Vergleich dargestellten Zellkern in der Interphase sind verschiedene Stadien der Mitose gezeigt (entsprechend der deutschen Literatur, daher ohne Prometaphase).
![Page 5: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/5.jpg)
Schematische Darstellung des Zellzyklus. Zur besseren Veranschaulichung sind Chromosomen hier auch in Interphase so gezeichnet, wie sie in der Mitose aussehen. Dies entspricht jedoch nicht der Wirklichkeit.
![Page 6: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/6.jpg)
Schematic of the cell cycle. Outer ring: I=Interphase, M=Mitosis; Inner ring: M=Mitosis, G1=Gap 1, G2=Gap 2, S=Synthesis; Not in ring: G0=Gap 0/Resting.
The Cell Cycle
![Page 7: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/7.jpg)
Cell cycle control was studied in early embryogenesis of frogs, yeasts and
mammalian cells.
The mechanisms and involved molecules are highly conserved
The names are sometimes confusing!
![Page 8: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/8.jpg)
Cell division and duplication of cellular constituents
•DNA
•Proteins, Lipids, Carbohydrates
•Organelles, Membranes...
![Page 9: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/9.jpg)
Standard versus early embryonic cell cycle
•in early embryonic cells DNA replication is uncoupled from other synthesis
•The eggs contain more cytoplasm than normal cells: Stocks•Some organisms have eggs with 100.000times more cytoplasm than normal cells•16 –17 divisions are possible without significant protein production. •These divisions are running without feedback control
![Page 10: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/10.jpg)
Methods to measure cell division
•Counting
•Amount of DNA
•Enzymatic activities
•Incorporation of labeled DNA precursors
•Cell cycle analysis (FACS)
•Dilution of dyes (CFSE)
•Time lapse microscopy
![Page 11: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/11.jpg)
CFSE (Carboxyfluorescein succinimidyl ester) is a fluorescent cell staining dye. CFSE is commonly confused with CFDA-SE, although they are not strictly the same molecule; CFDA-SE is cell permeable, while CFSE is not. As CFDA-SE enters the cell cytoplasm, intracellular esterases convert the molecule to the fluorescent ester, CFSE, which is retained within cells.CFSE is a simple and sensitive technique for analysis of multiple parameters of cells. This method allows us to examine specific populations of proliferating cells and identify 7–10 successive cell generations, which has first been employed to detect proliferation of T cells in experimental animals.[1] CFSE consists of a fluorescent molecule containing a succinimydyl ester functional group and two acetate moieties. CFSE diffuses freely inside the cells and intracellular esterases cleave the acetate groups converting it to a fluorescent, membrane impermeable dye. This dye is not transferred to adjacent cells. CFSE is retained by the cell in the cytoplasm and does not adversely affect cellular function. During each round of cell division, relative fluorescence intensity of the dye is decreased by half. In addition, unlike other methods, CFSE-labeled viable cells can be recovered for further analysis.
![Page 12: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/12.jpg)
FACS profiles of resting and growing cells
G1 82% S 12%G2 6%
G1 33% S 47%G2 19%
![Page 13: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/13.jpg)
Kinases control the progression through the cell cycle
Example MPF (maturation promoting factor)
MPF is composed of a cyclin and a cyclin dependent protein kinase (cdk)
![Page 14: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/14.jpg)
While cdks are constitutively expressed the appearance of cyclins in the cell cycle is transient – they
cycle
The presence of cyclins regulates the activity of the cdks
![Page 15: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/15.jpg)
Yeasts only have one Cyclin kinase (cdk1)
![Page 16: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/16.jpg)
Cyclic activity of Cyclin kinases
Temporal control of the animal cell cycle. The cyclin-E-, cyclin-A- and cyclin-B-dependent kinases are active at different times in the cell cycle. On this basis, cyclin E–Cdk2 appears to have a role in promoting S phase, cyclin A–Cdk2 in S phase and at G2-to-M phase, and cyclin B–Cdk1 during mitosis. Cyclin B1–Cdk1 is activated at the end of G2 phase by the phosphatase Cdc25.
![Page 17: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/17.jpg)
Cyclin kinases
![Page 18: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/18.jpg)
Targets of cyclin kinases:the G2 Kinase complex (MPF)
![Page 19: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/19.jpg)
The kinase activity of cdc-cyclin compexes is regulated by
phosphorylation and dephosphorylation
ExampleMO16 is an activating kinaseWee1 is an inhibitory kinase
cdc25 is a phosphatase that removes the inhibitory phosphate from the
cdk
![Page 20: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/20.jpg)
Regulation of cyclin-dependent kinases. Arrowheads represent activating events and perpendicular ends represent inhibitory events. Genes known to perform the indicated functions are listed below. Both cyclins and some CKIs (Cdk inhibitors) are regulated by synthesis and ubiquitin-mediated proteolysis. Checkpoint pathways could act to promote inhibitory pathways or inhibit activating pathways to cause cell cycle arrest
![Page 21: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/21.jpg)
The progression through the cell cycle underlies many controls:
Example DNA replication
A re-replication block ensures that no segment of DNA is replicated more
than once
Passage through mitosis removes the re-replication block
Feedback controls generally depend on inhibitory signals
![Page 22: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/22.jpg)
Checkpoint pathways
(A) A genetic pathway illustrating intrinsic and extrinsic checkpoint mechanisms. Letters represent cell cycle processes. The pathway shown as red symbols indicates an intrinsic checkpoint mechanism that operates to ensure that event C is completed before event E. After event B is completed, an inhibitory signal is activated that blocks completion of event E. After event C is completed, a signal is sent to turn off the inhibitory signal from B, thereby allowing completion of E. The blue symbols represent an extrinsic mechanism that is activated when defects such as DNA damage or spindle errors are detected. It is arbitrarily located on the D to E pathway but could also function by inhibiting a later step in the B to C pathway. In that case, the extrinsic
pathway would utilize the intrinsic mechanism for cell cycle arrest. Mutations in any of the red or blue symbols would result in a checkpoint-effective phenotype.
![Page 23: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/23.jpg)
Checkpoint pathways (B) Schematic representation of several cell cycle checkpoints. The colored arrows depict complex signaling pathways that operate in G1 to transmit information regarding cell proliferation. The red lines connecting particular
events and cell cycle transitions represent the inhibitory signals generated by checkpoint pathways in response to those events. The points of contact of the negative growth factor and contact inhibition pathways with the cell cycle are arbitrary and meant to indicate arrest in G1.
![Page 24: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/24.jpg)
http://www.1lec.com/Genetics/Cell%20Growth/index.html
![Page 25: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/25.jpg)
Activation of DNA replication through gene expression in G1
G0 G1 S
early response genes: fos, jun,..
delayed response genes: E2FCyclins E, D
DNA synthesis genes
Activation of
![Page 26: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/26.jpg)
Resting cells:The retinoblastoma protein Rb blocks
cell cycle progression in G1 by binding to and sequestering E2F
Rb+ E2F
Rb-P
Phosphorylation causes Inactivation of Rb
Rb : E2F
![Page 27: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/27.jpg)
Proliferation
Cell cycle progression by growth factors
Rb E2F
Rb-P
Phosphorylation causes Inactivation of Rb
Rb: E2F
Rb captures E2F: E2F cannot activate proproliferative genes
CyclinD.cdk4
CyclinD
Ras
MAPK pathway
EGF
![Page 28: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/28.jpg)
Rb+ E2F
Rb-P
Phosphorylation causes Inactivation of Rb
Rb captures E2F, so that it cannot activate proproliferative genes
Proliferation Growth block
CyclinD.cdk4
CyclinD
P16 Ink4A
Ras
MAPK pathway
Cell cycle progression
Rb: E2F
![Page 29: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/29.jpg)
Rb+ E2F
Rb-P
Rb captures E2F, so that it cannot activate proproliferative genes
CyclinD.cdk4
CyclinD
p16 Ink4A
Ras
MAPK pathway
p21
p53
CyclinE.cdk2
p27
p53 is a transcriptional activator:One of the genes induced by p53 is p21, an inhibitor of the cdk4 kinase
activity
Rb: E2F
![Page 30: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/30.jpg)
P53 is a general gatekeeper for the G1 checkpoint
![Page 31: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/31.jpg)
P53 is a DNA binding protein
![Page 32: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/32.jpg)
DNA damage leads to a block in cell cycle progression
Replication of damaged DNA would fix mutations for all daughter cells
![Page 33: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/33.jpg)
Possible biochemical function of the Rad24 group of checkpoint proteins. Rad24, together with the four small subunits of RFC, is a component of a pentameric complex. By analogy with RFC, this complex might recognise the transition between ssDNA and dsDNA. Such a structure is produced by many repair pathways but the Rad24 complex may only efficiently recognise it in the context of repair complexes (not shown here). Once the Rad24 complex is bound, it then functions to recruit the ‘PCNA-like’ Rad17/Mec3/Ddc1 complex to the DNA, followed by additional recruitment of checkpoint proteins involved in signal transduction (e.g. Mec1 and Rad53)
![Page 34: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/34.jpg)
Organisation of the DNA-damage-dependent checkpoint pathways of budding yeast. Two distinct types of DNA damage, in the context of repair complexes, are represented in the schematic. Some of the components of the NER complex, specific for UV photoproducts, are indicated. The pointers indicate the incisions generated by the structure-specific endonucleases ERCC1/XPF and XPG. The Rad50/Mre11/Xrs2 complex is involved in DSB repair. RAD9 and RAD24 define upstream ‘sensor’ branches of the pathway and seem to respond, primarily outside of S phase, to multiple types of DNA damage. Currently, no other members of the RAD9 branch have been identified but the RAD24 branch can be ordered genetically as shown although strict linearity of function within this branch is unlikely. Both the RAD9 and RAD24 branches converge on MEC1, a member of the PI3 kinase family. Within S phase, one or more independent pathways for sensing DNA damage exist. The S-phase-specific sensing pathways are also thought to converge on MEC1. The MEC1, RAD53 and CHK1 genes encode transducers of the checkpoint signal. These transducers regulate effectors that control the biological consequences, as indicated, of activation of this pathway. Effectors for Rad53 include: Dun1, involved in G2/M arrest and DDR induction; Swi6, encodes a transcription factor targeted by the G1 checkpoint); Pol -primase, a target of the S-phase checkpoint; and Cdc5, a ‘polo-like’ kinase which inhibits Clb/Cdc28 kinase. Chk1 seems to primarily regulate Pds1, a regulator of sister chromatid cohesion. There may be other MEC1-dependent, RAD53-independent effector pathways. Whether induction of efficient repair requires DDR induction is unclear but there is probably a contribution from post-transcriptional mechanisms.
![Page 35: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/35.jpg)
Mammalian cells:
The protein p53 is sensing DNA damage
P53 has a very high turn-over
DNA damage: p53 becomes phosphorylated and stabilized
![Page 36: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/36.jpg)
The Events in p53 Activation DNA damage (indicated by the break in the double line at the top) is recognized by a "sensor" molecule that identifies a specific type of lesion and possibly by the p53 protein, using its C-terminal domain. The sensor modifies p53 (by phosphorylation) when both molecules correctly determine that there is damage. A modified p53 is more stable (enhanced half-life), and a steric or allosteric change in p53 permits DNA binding to a specific DNA sequence regulating several downstream genes (p21, MDM2, GADD45, Bax, IGF-BP, and cyclin G). Two modes of signaling for cellular apoptosis are possible: one requiring transcription and one involving direct signaling with no transcription of downstream genes required.
![Page 37: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/37.jpg)
Cellular products influencing the cell cycle
![Page 38: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/38.jpg)
![Page 39: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/39.jpg)
![Page 40: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/40.jpg)
Viral and cellular proteins influencing p53 activity
![Page 41: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/41.jpg)
Cell cycle control in mono- versus multicellular systems
•Monocellular systems: Unlimited proliferationControl by size, nutrients and sex
•Multicellular systems: Proliferation is limited to specific regions and circumstances: Growth factors, cell:cell-interactions,
In mammals growth and proliferation are independently regulated
![Page 42: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/42.jpg)
Influence of cellular and viral proteins in the cell cycle machinery
![Page 43: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/43.jpg)
EGFreceptor
FGFreceptor
Extracellularligand bindingdomain
Transmembranedomain
Tyrosinekinase domain
Growth factor stimulation through membrane receptors
![Page 44: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/44.jpg)
EGF-receptor
Tyrosine kinase
Growth factor stimulation through a membrane receptor
Rb E2F
Rb-P
Phosphorylation causes Inactivation of Rb
Rb: E2F
Rb captures E2F: E2F cannot activate proproliferative genes
CyclinD.cdk4
CyclinD
Ras
MAPK pathway
EGF
![Page 45: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/45.jpg)
TGFß-R
Anti-Growth-Factors e.g. TGFß
SmadsCycl D:CDK4
RB
Changes in Gene Expression
p15
E2Fs
Cell Proliferation(Cell Cycle)
p16
p21
p27
Cycl E:CDK4 -
Cell growth inhibitors that act through a membrane receptor
![Page 46: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/46.jpg)
Cancer and the cell cycle
![Page 47: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/47.jpg)
Introduction
• accumulation of multiple mutations within genes of a single cell
• mutations confer a competitive advantage for cell growth and (de-) differentiation
• mutations lead to initiation and progression of malignancies
Current view:
![Page 48: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/48.jpg)
![Page 49: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/49.jpg)
• control cell proliferation and differentiation• are expressed in all subcellular compartments
(nucleus, cytoplasm, cell surface)• act as protein kinases, growth factors, growth factor
receptors, or membrane associated signal transducers
Proto-oncogenes
![Page 50: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/50.jpg)
Oncogenes
• Mutations in proto-oncogenes alter the normal structure and/or expression pattern
• Act in a dominant fashion gain of function
![Page 51: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/51.jpg)
Mechanisms of oncogene action
• phosphorylation of proteins, with serine, threonine and tyrosine as substrates
• signal transmission by GTPases • regulation of DNA transcription
Biochemically, there are three known mechanisms by which these genes act:
![Page 52: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/52.jpg)
Tumor Suppressor Genes
• Have normal, diverse functions to regulate cell growth in a negative fashion (restrain neoplastic growth; act as cellular “brakes”)
• physical or functional loss of both alleles frees the cell from constraints imposed by their protein products loss of function
![Page 53: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/53.jpg)
What causes cancer?
• Chemical Carcinogenes– Aflatoxin B1,, Vinylchloride, β-Propiolacton
Dimethylsulfate ...
• Radiation:– UV, X-Ray, α,-β,-γ-radiation
• Viruses– RNA-viruses, DNA-viruses
• Spontaneoud mutations Loss of DNA-repair machinery p53
![Page 54: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/54.jpg)
„... manifestation of six essential alterations in cell physiology that collectively dictate malignant growth.“
Cell, Vol. 100, 2000
1. Self-Sufficiency in Growth Signals
6. Tissue Invasion and Metastasis
5. Sustained Angiogenesis
4. Limitless Replicative Potential
3. Evading Apoptosis
2. Insensitivity to Antigrowth Signals
![Page 55: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/55.jpg)
• Cancer cell strategies:– Alteration of extracellular growth signals– Alteration of transcellular transducers of
growth signals– Alteration of intracellular circuits that
translate growth signals – Synthesis of „own“ GS autocrine
stimulatione.g. production of PDGF, TGFα by glioblastomas and sarcomas
1. Self-Sufficiency in Growth Signals
![Page 56: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/56.jpg)
1. Self-Sufficiency in Growth Signals
growth signals (PDGF, TGFα) --> autocrine stimulation overexpression or mutation of receptors (EGF-R, HER2)
disruption of intracellular circuits (SOS-Ras-Raf -Map-Kinase)
![Page 57: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/57.jpg)
EGF-receptor
Tyrosine kinase
1. Self-Sufficiency in Growth Signals
![Page 58: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/58.jpg)
TGFß-R
Anti-Growth-Factors e.g. TGFß
SmadsCycl D:CDK4
RB
Changes in Gene Expression
p15
E2Fs
Cell Proliferation(Cell Cycle)
p16
p21
p27
Cycl E:CDK4 -
2. Insensitivity to Antigrowth Signals
![Page 59: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/59.jpg)
2. Insensitivity to Antigrowth Signals
Disruption of Rb-pathway, downregulation of death receptors
![Page 60: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/60.jpg)
Apoptotic machinery: sensors and effectors
Survival signals:
IGF-1/IGF-2 Receptor: IGF-1R
IL-3 Receptor: IL-3R
Death signals:
FAS Receptor: FAS-R
TNFα Receptor: TNF-R1
3. Evading Apoptosis
![Page 61: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/61.jpg)
• There are both proapoptotic genes (cell death agonists such as Bax, Bak, Bid, Bim) and antiapoptotic genes (cell death antagonists such as Bcl-2, Bcl-xL)
• The prototypic gene in this category is Bcl-2
3. Evading Apoptosis
Intracellular signals:
![Page 62: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/62.jpg)
3. Evading Apoptosis
Loss of proapoptotic regulators (p53), nonsignaling deathreceptors (FAS)
![Page 63: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/63.jpg)
FAS-
R
Death Factor
Caspase 8 FADD
CELL DEATH
Cytochrom C
Caspase 9
MITOAbnormality
sensorBim, etc.
DNA damagesensorp53Bax
Bid
3. Evading Apoptosis
FAS-
R
![Page 64: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/64.jpg)
• With each cell division, there is a shortening of specific tracts of DNA at the ends of chromosomes (50 – 100 bp)
• These tracts are called telomeres and are composed of repetitive DNA sequences
• Once shortened beyond a certain point, cells die• Telomere shortening, therefore, acts as a clock
that counts cell divisions
4.Limitless Replicative Potential
![Page 65: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/65.jpg)
• In germ cells, telomere shortening is prevented by the enzyme complex telomerase
• Telomerase adds back any repetitive telomere sequences lost after a cell division
• Most somatic cells lack telomerase• For a cell to divide indefinitely, it must prevent
telomere shortening• Tumor cells do this by activating telomerase
4.Limitless Replicative Potential
![Page 66: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/66.jpg)
• Angiogenesis (growth of new blood vessels)
• Cells reside within 100 µm of a blood vessel (nutrients/oxygen supply)
• Regulating signals may stimulate/block angiogenesis
• Initiating signals: e.g. VEGF/ bFGF
• Inhibitor signals: e.g. Thrombospondin-1
5. Sustained Angiogenesis
![Page 67: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/67.jpg)
5. Sustained Angiogenesis
Increased expression of angiogen. inducers (VEGF, bFGF) loss of p53 -->downregulation of inhibitors (thrombospondin-1)
![Page 68: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/68.jpg)
• Tumor cells change the Inducer/Inhibitor balance• Possibilities:
– Increased expression of VEGF/FGF– Downregulation of Thrombospondine-1,
or ß-interferon
• Loss of p53 Thrombospondine-1• Activation of ras Increased expression of VEGF• Proteases release bFGF stored in the ECM
5. Sustained Angiogenesis
![Page 69: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/69.jpg)
6. Tissue Invasion and Metastasis
![Page 70: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/70.jpg)
• Affected proteins: – cell-cell-adhesion molecules (CAMs) e.g.
Ca-dependent cadherin families– Integrins responsible for linking cells to
extra cellular matrix (ECM)
6. Tissue Invasion and Metastasis
![Page 71: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/71.jpg)
α β
Actin, Myosin II, Tropomyosin
Integrin
Fibronectin
Α-Actinin, Vinculin
6. Tissue Invasion and Metastasis
![Page 72: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/72.jpg)
E-cadherin Ca2+ Cell-to-Cell coupling by E-cadherin
Signal transmission
Signal transmission
6. Tissue Invasion and Metastasis
![Page 73: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/73.jpg)
• Cancer cells use extracellular proteases to facilitate invasion into: nearby stroma, across blood vessel walls, „normal“ epithelian cells
• Upregulation of protease genes, downregulation of inhibitor genes
• Inactive zymogen forms of proteases are converted into active enzymes
• Often cancer cell contacted stromal and inflammatory cells deliver the proteases
6. Tissue Invasion and Metastasis
![Page 74: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/74.jpg)
6. Tissue Invasion and Metastasis
„Out-of-order“ CAMs (E-cadherin), changing integrin expression pattern, overexpression of extracellular proteases, downregulation of protease inhibitor genes
![Page 75: The Cell Cycle and its implications in diseases Hansjörg Hauser Dept. of Gene Regulation and Differentiation Molecular Biotechnology HZI, Braunschweig](https://reader030.vdocuments.site/reader030/viewer/2022032723/56649d0b5503460f949de3af/html5/thumbnails/75.jpg)
Summary
„... manifestation of six essential alterations in cell physiology that collectively dictate malignant growth.“Cell, Vol. 100, 2000